Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6402 posts found.

Mundipharma and Cidara Therapeutics report positive Phase III results into candidemia treatment

April 26, 2022 Medical Communications

Mundipharma and Cidara Therapeutics have presented data from the Phase III ReSTORE trial of rezafungin, in the treatment of candidemia …
News

Vivesto signs agreement with CRO to evaluate anti-cancer drug formulations

April 22, 2022 Medical Communications

Vivesto AB, an oncology-focused pharmaceutical company, has announced that it is advancing research into its proprietary drug delivery formulations, and …
News

Orasis Pharmaceuticals announces positive Phase III results of eye drop candidate

April 22, 2022 Medical Communications

Orasis Pharmaceuticals has announced that the Phase III NEAR-1 and NEAR-2 clinical trials, which evaluated the efficacy and safety of …
News

FDA approves Phase III Acute Respiratory Distress Syndrome (ARDS) Trial

April 22, 2022 Medical Communications

The FDA has approved Direct Biologics to proceed with its Phase III clinical trial into the treatment of Acute Respiratory …
News

WHO “strongly recommends” Paxlovid, calls for wide distribution from Pfizer

April 22, 2022 Medical Communications

WHO has endorsed the use of Pfizer’s oral antiviral treatment for high-risk patients with mild COVID-19, following an analysis of …
News

NICE publishes guidance for atopic dermatitis treatments

April 8, 2022 Medical Communications

Abrocitinib, upadacitinib, and tralokinumab are not recommended for treating moderate to severe atopic dermatitis. The recommendation does not affect patients …
News

First-of-its-kind vaccine manufacturing facility shipped to Africa

April 8, 2022 Medical Communications

KeyPlants announced the shipping a first-of-its-kind vaccine manufacturing filling facility to Senegal, in West Africa.
News

Acadia seeks first-ever FDA approval in Rett Syndrome

April 8, 2022 Medical Communications

Acadia has presented an update on its Phase III LAVENDER study of trofinetide for Rett Syndrome at the American Academy …
News

NIH funds tuberculosis research advancement centres

April 8, 2022 Medical Communications

News
leipzig_skyline

FlyPharma Conference Europe: New dates and location announced

April 4, 2022 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

FlyPharma Conferences are pleased to announce that FlyPharma Europe is returning as a live, in-person event in 2022.
News

FDA places two clinical holds on CytoDyn HIV and COVID-19 programmes

April 1, 2022 Medical Communications

The FDA has placed a partial hold on CytoDyn’s HIV program, and a full clinical hold on its COVID-19 program …
News

Biomodex launches clear cartridges for neurovascular training

April 1, 2022 Medical Communications

Biomodex has announced the launch of clear cartridges for use with Biomodex’s EVIAS and EVIAS Plus stations.The cartridges are 3D …
News

Isturisa effective in treating rare Cushing’s disease

April 1, 2022 Medical Communications

Recordati Rare Diseases has announced the publication of positive results from the Phase III LNC 4 study, confirming the efficacy …
News

UK app launched for people living with glaucoma

April 1, 2022 Medical Communications

Santen UK has launched a new app for people living with glaucoma, in partnership with Glaucoma UK, the leading charity …
News

After pressure from patients, ALS drug reviewed by FDA

March 25, 2022 Medical Communications

The FDA is meeting next week to review a drug closely watched for ALS, also known as Lou Gehrig’s disease, …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025